Pharmaceuticals
TrendingAPI Holdings (Pharmeasy)
India's leading digital healthcare platform navigating a post-funding-winter reset in private valuations.
Indicative Price
₹9
1Y Change
+49.3%
Market Lot
100
Lot Value
₹900
Market Cap
₹15,000 Cr
Buy in 3 simple steps
- 1Quantity
- 2
- 3
How many shares?
Minimum lot · 100 shares
Order value
₹900
Price History — 18 Months
Indicative unlisted-market prices · illustrative sample data
Desk Research Notes
PharmEasy remains India's largest e-pharmacy by scale, but the reset in private-market valuations after the funding winter has compressed its unlisted price sharply from peak levels.
The desk tracks it as a high-beta turnaround: cash burn has narrowed, debt has been restructured, and any successful listing would re-rate the counter — with equally meaningful downside risk.
Key Financials
| Metric | FY24 | FY25 |
|---|---|---|
| Revenue (₹ Cr) | 5,900 | 6,400 |
| PAT (₹ Cr) | -2,400 | -1,600 |
| Gross Margin (%) | 18 | 22 |
| Cash Burn (₹ Cr) | 1,900 | 1,100 |
Illustrative figures · verify with latest filings
Frequently Asked
Why is the price so low versus its peak?
Private valuations were marked down heavily after its IPO was withdrawn; the current price reflects that reset.
Is this suitable for conservative investors?
No — this is a high-risk turnaround counter. Size positions accordingly.
What would re-rate the stock?
Sustained profitability, debt reduction and a credible renewed IPO timeline.
Interested in API Holdings (Pharmeasy)?
Request a current desk quote — availability and pricing confirmed within one business day.